Arthritis, Rheumatoid

Is the Rheumatoid Arthritis Impact of Disease (RAID) score a meaningful instrument for other inflammatory rheumatic diseases? A cross-sectional analysis of data from the German National Database
Katja Thiele, Katinka Albrecht, Angela Zink, Martin Aringer, Kirsten Karberg, Susanna Späthling-Mestekemper, Ulrich von Hinüber, Johanna Callhoff

RMD Open Jul 2022, 8 (2) e002342; DOI: 10.1136/rmdopen-2022-002342
Risk of malignancy in rheumatoid arthritis patients initiating biologics: an historical propensity score matched cohort study within the French nationwide healthcare database
Raphaele Seror, Alexandre Lafourcade, Yann De Rycke, Sandrine Pinto, Johann Castaneda, Bruno Fautrel, Xavier Mariette, Florence Tubach

RMD Open Jun 2022, 8 (2) e002139; DOI: 10.1136/rmdopen-2021-002139
Levelling the playing field of RMD research across Europe to address patients’ needs: the emerging EULAR Research Centre
Katja Reuter, Carina Haupt, Anna Molto, Andrew Cope, Ronald F van Vollenhoven, Dirk Elewaut, Rik Lories, Iain B McInnes

RMD Open Jun 2022, 8 (2) e002456; DOI: 10.1136/rmdopen-2022-002456
Active counselling and well-controlled disease result in a higher percentage of women with rheumatoid arthritis that breast feed: results from the PreCARA study
Erik Kemper, Nafise Ghalandari, Hetty Wintjes, Anneke Van Steensel-Boon, Laura Kranenburg, Annemarie Mulders, Hubertina Crijns, Hieronymus Smeele, Radboud J EM Dolhain

RMD Open Jun 2022, 8 (2) e002194; DOI: 10.1136/rmdopen-2022-002194
Therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal disease: a systematic literature review informing EULAR points to consider
Charlotte Krieckaert, Borja Hernández-Breijo, Johanna Elin Gehin, Guillaume le Mélédo, Alejandro Balsa, Meghna Jani, Denis Mulleman, Victoria Navarro-Compan, Gertjan Wolbink, John Isaac, Astrid van Tubergen

RMD Open Jun 2022, 8 (2) e002216; DOI: 10.1136/rmdopen-2022-002216
Very low rate of humoral response after a third COVID-19 vaccine dose in patients with autoimmune diseases treated with rituximab and non-responders to two doses
Samuel Bitoun, Jérôme Avouac, Julien Henry, Roba Ghossan, Omar Al Tabaa, Rakiba Belkhir, Gaetane Nocturne, Alice Andrée Mariaggi, Flore Rozenberg, Christelle Vauloup-Fellous, Xavier Mariette, Raphaèle Seror

RMD Open May 2022, 8 (1) e002308; DOI: 10.1136/rmdopen-2022-002308
Efficacy of tofacitinib in patients with rheumatoid arthritis stratified by baseline body mass index: an analysis of pooled data from phase 3 studies
Ara H Dikranian, Miguel A Gonzalez-Gay, Frank Wellborne, José María Álvaro-Gracia, Liza Takiya, Lori Stockert, Jerome Paulissen, Harry Shi, Svitlana Tatulych, Jeffrey R Curtis

RMD Open May 2022, 8 (1) e002103; DOI: 10.1136/rmdopen-2021-002103
Positive impact on 10-year outcome of the window of opportunity for conventional synthetic DMARDs in rheumatoid arthritis: results from the ESPOIR cohort
Joanna Kedra, Alexandre Lafourcade, Bernard Combe, Maxime Dougados, David Hajage, Bruno Fautrel

RMD Open May 2022, 8 (1) e002040; DOI: 10.1136/rmdopen-2021-002040
Does an adjustment to the dosing and timing of immunomodulatory drugs alter the immunogenicity of the COVID-19 vaccines in patients with autoimmune and inflammatory rheumatic disease (AIIRD)?
Andrew J Laster, Gordon K Lam, Heather S Gladue, Ahmad A Kashif, Erin P Siceloff, Virginia D Lackey, Cheryl R Robertson, Ashley L Toci, Leonard H Calabrese

RMD Open May 2022, 8 (1) e002203; DOI: 10.1136/rmdopen-2022-002203
Association between social deprivation and disease activity in rheumatoid arthritis: a systematic literature review
Mrinalini Dey, Amanda Busby, Helen Elwell, Heidi Lempp, Arthur Pratt, Adam Young, John Isaacs, Elena Nikiphorou

RMD Open Apr 2022, 8 (1) e002058; DOI: 10.1136/rmdopen-2021-002058

Main menu

Arthritis, Rheumatoid

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Arthritis, Rheumatoid

Pages